Tradestie Institutional Equity Comparison Engine
VVOS vs NMTC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMTC Overall Edge
NMTC Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeuroOne Medical Technologies Corporation Common Stock (NMTC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
VVOS N/M vs NMTC N/M Fwd P/E
Growth & Margin Winner
NMTC
Op Margin -107.9% vs -63.4% ยท YoY +34.9% vs +16.3%
Momentum & Technical Winner
NMTC
1Y -97.7% vs +3.5% ยท 52W Pos 0% vs 2%
Options & Structure Winner
NMTC
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
NMTC
NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap
$6.1M
1M Return
-33.46%
1Y Return
+3.49%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 60.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
NMTC +3.49%
Spread: +101.2 pp (NMTC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VVOS Revenue | NMTC Revenue | VVOS Op. Margin | NMTC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2014 | N/A | $0M | N/A | -4646.1% | NMTC |
| FY2019 | $10M | N/A | -92.8% | N/A | VVOS |
| FY2020 | $10M | N/A | -92.1% | N/A | VVOS |
| FY2021 | $20M | $0M | -120.7% | -5735.9% | VVOS |
| FY2022 | $20M | $0M | -156.2% | -5860.2% | VVOS |
| FY2023 | $10M | $0M | -125.3% | -612.3% | VVOS |
| FY2024 | $20M | $0M | -74.3% | -344.3% | VVOS |
| FY2025 | $20M | $10M | -114.1% | -46.5% | NMTC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | NMTC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | $6.1M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +34.9% | +16.3% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -107.9% | -63.4% | Higher Margin | NMTC |
| Net Profit Margin Profitability | -121.8% | -59.7% | Higher Margin | NMTC |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | -124.7% | Higher ROE | NMTC |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 2% ($1โ$5) | Stronger Trend | NMTC |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 1.55ฮฒ ยท 105% Vol | Lower Realized Risk | NMTC |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 45.5 / 100 (HOLD) | Higher Composite | NMTC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs NMTC Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NMTC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor NMTC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.